parthenolide and Left Ventricular Hypertrophy

parthenolide has been researched along with Left Ventricular Hypertrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aro, J; Kerkelä, R; Leskinen, H; Ruskoaho, H; Rysä, J; Saiho, T; Serpi, R; Skoumal, R; Szokodi, I; Tóth, M; Ulvila, J	1

Other Studies

1 other study(ies) available for parthenolide and Left Ventricular Hypertrophy

Article	Year
Parthenolide inhibits STAT3 signaling and attenuates angiotensin II-induced left ventricular hypertrophy via modulation of fibroblast activity. Journal of molecular and cellular cardiology, 2011, Volume: 50, Issue:4 Topics: Angiotensin II; Animals; Blotting, Western; Echocardiography; Electrophoretic Mobility Shift Assay; Fibroblasts; Hemodynamics; Hypertrophy, Left Ventricular; Immunohistochemistry; Male; Phosphorylation; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor	2011

Article

Year

Parthenolide inhibits STAT3 signaling and attenuates angiotensin II-induced left ventricular hypertrophy via modulation of fibroblast activity.

Journal of molecular and cellular cardiology, 2011, Volume: 50, Issue:4

Topics: Angiotensin II; Animals; Blotting, Western; Echocardiography; Electrophoretic Mobility Shift Assay; Fibroblasts; Hemodynamics; Hypertrophy, Left Ventricular; Immunohistochemistry; Male; Phosphorylation; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor

2011